The PE Ratio as of June 2026 (TTM) for Ascentage Pharma Group International (AAPG) is -8.54

According to Ascentage Pharma Group International’s latest financial reports and current stock price. The company's current PE Ratio is -8.54. This represents a change of 400.10% compared to the average of -1.71 of the last 4 quarters.

Ascentage Pharma Group International (AAPG) Historical PE Ratio (quarterly & annually)

How has AAPG PE Ratio performed in the past?

The mean historical PE Ratio of Ascentage Pharma Group International over the last ten years is -7.86. The current -8.54 PE Ratio has changed 10.76% with respect to the historical average. Over the past ten years (40 quarters), AAPG's PE Ratio was at its highest in in the June 2024 quarter at 14.35. The PE Ratio was at its lowest in in the June 2018 quarter at -175.82.

Ascentage Pharma Group International (AAPG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ascentage Pharma Group International PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascentage Pharma Group International (AAPG) Average PE Ratio

How has AAPG PE Ratio performed in the past?

The current PE Ratio of Ascentage Pharma Group International (AAPG) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Ascentage Pharma Group International (AAPG) PE Ratio vs. Peers

How is AAPG’s PE Ratio compared to its peers?

Ascentage Pharma Group International’s PE Ratio is greater than Centessa Pharmaceuticals plc (-24.33), greater than Apogee Therapeutics, Inc. (-22.41), greater than Celcuity Inc. (-25.00), greater than Xenon Pharmaceuticals Inc. (-11.88), greater than CG Oncology, Inc. Common stock (-26.96), greater than Zai Lab Limited (-10.47), greater than Legend Biotech Corporation (-26.49), less than Ultragenyx Pharmaceutical Inc. (-4.02), greater than Disc Medicine, Inc. (-10.83), less than Soleno Therapeutics, Inc. (28.75),

Build a custom stock screener for Ascentage Pharma Group International (AAPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascentage Pharma Group International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascentage Pharma Group International (AAPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascentage Pharma Group International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.